Clinical Trial Update: A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety, efficacy, and pharmacokinetics of the recombinant Factor IX–albumin fusion protein rIX-FP in children with Hemophilia B; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• IdElvion

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2016-05-09